Showing results (41-50 of 52) with videos related to
Sort By:
Pageof 6
Journal of Immunology Research|April 13, 2026
C3d Complement Activation and Antibody Immunity in Convalescent COVID-19: Insights From Adults and ChildrenRatna Wijaya, Jordan Stoddart, Anurag Adhikari, et al.Research Square|March 30, 2023
Clinical Outcomes and Prognostic Factors in Triple-Negative Invasive Lobular Carcinoma of the BreastUtsav Joshi, Pravash Budhathoki, Suman Gaire, et al.Breast Cancer Research and Treatment|May 20, 2023
Clinical outcomes and prognostic factors in triple-negative invasive lobular carcinoma of the breastUtsav Joshi, Pravash Budhathoki, Suman Gaire, et al.Journal of Immunology (Baltimore, Md. : 1950)|September 27, 2022
Longitudinal Characterization of Phagocytic and Neutralization Functions of Anti-Spike Antibodies in Plasma of Patients after Severe Acute Respiratory Syndrome Coronavirus 2 InfectionAnurag Adhikari, Arunasingam Abayasingam, Chaturaka Rodrigo, et al.Clinical & Translational Immunology|December 5, 2023
Elevated BMI reduces the humoral response to SARS-CoV-2 infectionMarcus Zw Tong, Julian Dj Sng, Meagan Carney, et al.Cell Reports|January 29, 2022
Maintenance of broad neutralizing antibodies and memory B cells 1 year post-infection is predicted by SARS-CoV-2-specific CD4+ T cell responsesHarikrishnan Balachandran, Chansavath Phetsouphanh, David Agapiou, et al.Research Square|January 9, 2026
An HLA Association With COVID-19 Vaccine Reactogenicity Correlates With Fewer SARS-CoV-2 Infections and Monocyte ActivationJill Hollenbach, Anshika Srivastava, Demetra Chatzileontiadou, et al.Research Square|July 3, 2026
COVID-19 Vaccine Reactogenicity Marks an Innate Inflammatory Response Associated With HLA Variation and Enhanced ProtectionJill Hollenbach, Anshika Srivastava, Demetra Chatzileontiadou, et al.Journal of Virology|April 25, 2025
Twelfth scientific biennial meeting of the Australasian Virology Society: AVS12 2024Ebony A Monson, Robson K Loterio, Justin A Roby, et al.Nature Immunology|October 6, 2025
Profiling of HIV-1 elite neutralizer cohort reveals a CD4bs bnAb for HIV-1 prevention and therapyLutz Gieselmann, Andrew T DeLaitsch, Malena Rohde, et al.Pageof 6